Severe cholestasis related to intraconazole for the treatment of onychomycosis
- PMID: 10606333
- DOI: 10.1111/j.1572-0241.1999.01623.x
Severe cholestasis related to intraconazole for the treatment of onychomycosis
Abstract
We describe a case of prolonged cholestasis temporally associated with the use of itraconazole for onychomycosis. Peak bilirubin level of 32.0 mg/dl was documented approximately 2 months after discontinuation of the patient's itraconazole therapy, with symptoms of cholestasis persisting more than 1 month after the peak in bilirubin. Physicians should be aware of the potential for severe cholestasis associated with itraconazole usage.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources